JP2007506718A5 - - Google Patents

Download PDF

Info

Publication number
JP2007506718A5
JP2007506718A5 JP2006527485A JP2006527485A JP2007506718A5 JP 2007506718 A5 JP2007506718 A5 JP 2007506718A5 JP 2006527485 A JP2006527485 A JP 2006527485A JP 2006527485 A JP2006527485 A JP 2006527485A JP 2007506718 A5 JP2007506718 A5 JP 2007506718A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
aryl
heterocyclyl
benzimidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006527485A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007506718A (ja
Filing date
Publication date
Priority claimed from SE0302570A external-priority patent/SE0302570D0/xx
Application filed filed Critical
Publication of JP2007506718A publication Critical patent/JP2007506718A/ja
Publication of JP2007506718A5 publication Critical patent/JP2007506718A5/ja
Pending legal-status Critical Current

Links

JP2006527485A 2003-09-26 2004-09-24 ベンゾイミダゾール誘導体、それを含む組成物、その製造方法およびその使用 Pending JP2007506718A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0302570A SE0302570D0 (sv) 2003-09-26 2003-09-26 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
PCT/GB2004/004112 WO2005030761A1 (en) 2003-09-26 2004-09-24 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Publications (2)

Publication Number Publication Date
JP2007506718A JP2007506718A (ja) 2007-03-22
JP2007506718A5 true JP2007506718A5 (enExample) 2007-11-08

Family

ID=29246979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006527485A Pending JP2007506718A (ja) 2003-09-26 2004-09-24 ベンゾイミダゾール誘導体、それを含む組成物、その製造方法およびその使用

Country Status (7)

Country Link
US (1) US20070072853A1 (enExample)
EP (1) EP1673369A1 (enExample)
JP (1) JP2007506718A (enExample)
AR (1) AR045822A1 (enExample)
SE (1) SE0302570D0 (enExample)
TW (1) TW200524594A (enExample)
WO (1) WO2005030761A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0302573D0 (sv) 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302571D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
JP2008514595A (ja) * 2004-09-24 2008-05-08 アストラゼネカ・アクチエボラーグ 化合物、それを含有する組成物、その製造及びその使用ii
WO2006033629A1 (en) * 2004-09-24 2006-03-30 Astrazeneca Ab Benzimidazole derivatives and their use as cannabinoid receptor ligands
WO2006033632A1 (en) * 2004-09-24 2006-03-30 Astrazeneca Ab Benzimidazole derivatives and their use as cannabinoid receptor ligands I
WO2006033627A1 (en) * 2004-09-24 2006-03-30 Astrazeneca Ab Compounds, compositions containing them, preparation thereof and uses thereof iiii
BRPI0515897A (pt) * 2004-09-24 2008-08-12 Astrazeneca Ab composto, uso do mesmo, composição farmacêutica, e, método para a terapia de dor em um animal de sangue quente, e para a preparação de um composto
BRPI0517925A (pt) 2004-11-02 2008-10-21 Pfizer derivados de sulfonil benzimidazol
CN101365686A (zh) 2005-12-21 2009-02-11 沃泰克斯药物股份有限公司 作为离子通道调节剂的杂环衍生物
TW200745049A (en) 2006-03-23 2007-12-16 Astrazeneca Ab New crystalline forms
TW200808769A (en) * 2006-04-18 2008-02-16 Astrazeneca Ab Therapeutic compounds
ATE532770T1 (de) 2006-09-05 2011-11-15 Kyowa Hakko Kirin Co Ltd Imidazolderivat
US20110086853A1 (en) * 2009-10-08 2011-04-14 William Brown Therapeutic Compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE666351A (enExample) * 1964-07-02
FR5354M (enExample) * 1965-09-10 1967-09-11
DE4237597A1 (de) * 1992-11-06 1994-05-11 Bayer Ag Substituierte Benzimidazole
DE4237557A1 (de) * 1992-11-06 1994-05-11 Bayer Ag Substituierte Benzimidazole
DE4237617A1 (de) * 1992-11-06 1994-05-11 Bayer Ag Verwendung von substituierten Benzimidazolen
US6114532A (en) * 1998-02-03 2000-09-05 Boehringer Ingelheim Pharma Kg Bicyclic heterocycles, the preparation thereof, and their use as pharmaceuticals
DE19945787A1 (de) * 1999-09-24 2001-03-29 Boehringer Ingelheim Pharma Arylsulfonamid-substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7115645B2 (en) * 2000-01-14 2006-10-03 Schering Aktiengesellschaft 1,2 diarylbenzimidazoles and their pharmaceutical use
CN1301975C (zh) * 2000-01-14 2007-02-28 舍林股份公司 用于治疗与小胶质细胞活化有关的疾病的1,2-二芳基苯并咪唑衍生物
SE0101387D0 (sv) * 2001-04-20 2001-04-20 Astrazeneca Ab Novel compounds
MXPA05004434A (es) * 2002-10-24 2005-07-26 Sterix Ltd Inhibidores de 11-beta-hidroxi esteroide deshidrogenasa tipo 1 y tipo 2.
SE0301701D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301699D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302571D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Similar Documents

Publication Publication Date Title
JP2007506718A5 (enExample)
JP2007506721A5 (enExample)
JP2015517981A5 (enExample)
RU2283835C3 (ru) Производные гетероциклических соединений и лекарственные средства
JP2010501478A5 (enExample)
JP2005529946A5 (enExample)
PE20080077A1 (es) Derivados de sulfonilfenilo como antagonistas del receptor de il-8
DK1663182T3 (da) Hurtigt opløsende formulering af cinacalcet HCl
DE60233133D1 (de) Polymorphe formen von 1-ä4-(5-cyanoindol-3-yl)butylü-4-(2-carbamoylbenzofuran-5-yl) piperazin-hydrochlorid
JP2006526031A5 (enExample)
ME02323B (me) Spiro supstituisana jedinjenja kao inhibitori angiogeneze
JP2010504908A5 (enExample)
ATE348816T1 (de) 2,5-dioxoimidazolidin-4-ylacetamide und analoga als inhibitoren von metalloproteinase mmp12
CA2556944A1 (en) Thiazole derivative
NO20063383L (no) Krystall av salt av 4-(3-klor-4(cyklopropylaminokarbonyl)aminofenoksy)-7-metoksy-6-kinolinkarboksamid eller av solvat derav og fremgangsmater for fremstilling av disse
ATE465712T1 (de) Ultrafeine zusammensetzungen von formoterol
DK1436322T3 (da) Blandinger af cyclosporinanaloger og deres anvendelse som immunmodulerende midler
EA200601007A1 (ru) 7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы
JP2007508362A5 (enExample)
JP2007231005A5 (enExample)
JP2010520214A5 (enExample)
PE20061451A1 (es) Compuestos derivados de diarilsulfona sulfonamidas
EP1531795A4 (en) FORMULATIONS FOR LIMITING THE RETENTION OF LUNG INFECTIONS
RU2318814C2 (ru) Имидазолинилметиларалкилсульфонамиды
JP2007516211A5 (enExample)